Back in action. We make it happen.
Osteoarthritis and A2M
Alpha-2-macroglobulin (A2M) is a powerful inhibitor of cartilage catabolic factors and stops the progression of Osteoarthritis (OA) by preventing cartilage breakdown and preventing cartilage loss.
Orthopedic Surgeon Dr. Gaetano Scuderi offers a breakthrough molecular technology that concentrates the alpha-2-macroglobulin (A2M) in your blood to deliver high concentrations in your joint space, protecting your joint space from the destructive proteins that cause Osteoarthritis (OA).
The A2M therapy offered by Palm Beach Sports Injury Institute (PBSII) is FDA approved and utilizes an advanced filtration technology representing the forefront of regenerative medicine by utilizing the natural A2M in your blood to deliver high concentrations in your joint space.
If you have questions about A2M therapy, please call Palm Beach Sports Injury Institute (PBSII) at (561) 747-9334.
Dr. Gaetano Scuderi is the Founder and President of Cytonics Corporation. Cytonics Corporation is the leader in cartilage research and focuses on innovative product developments for Osteoarthritis utilizing Alpha-2-Macroglobulin (A2M) therapies. A2M injection therapy has shown exemplarily results for the treatment of Osteoarthritis in patients with knee pain, joint pain, and back pain. For more information on A2M treatment options and to see if you may benefit from an A2M injection contact PBSII. Additional information on Cytonics Corporation and A2M injection therapy research visit www.Cytonics.com
Palm Beach Sports Injury Institute is committed to improving patient health through prevention, diagnosis, treatment, and management of orthopedic and sports medicine injuries and disease.